Your browser doesn't support javascript.
loading
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Huang, Raymond Y; Bi, Wenya Linda; Weller, Michael; Kaley, Thomas; Blakeley, Jaishri; Dunn, Ian; Galanis, Evanthia; Preusser, Matthias; McDermott, Michael; Rogers, Leland; Raizer, Jeffrey; Schiff, David; Soffietti, Riccardo; Tonn, Jörg-Christian; Vogelbaum, Michael; Weber, Damien; Reardon, David A; Wen, Patrick Y.
Afiliação
  • Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Bi WL; Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Weller M; Department of Neurology, University Hospital Zurich, Zürich, Switzerland.
  • Kaley T; Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Blakeley J; The Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Dunn I; Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Galanis E; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Preusser M; Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Centre, Medical University Vienna-General Hospital, Vienna, Austria.
  • McDermott M; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
  • Rogers L; Radiation Oncology, Barrow Neurological Institute, Phoenix, Arizona, USA.
  • Raizer J; Medical Neuro-Oncology, Northwestern Medicine, Chicago, Illinois, USA.
  • Schiff D; Departments of Neurology, Neurological Surgery, and Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Soffietti R; Department of Neuro-Oncology, University of Turin and City of Health and Science University Hospital, Torino, Italy.
  • Tonn JC; Department of Neurosurgery, Ludwig-Maximilians-Universität, Munich, Germany.
  • Vogelbaum M; Rose Ella Burkhardt Brain Tumor and Neuro Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Weber D; Paul Scherrer Institut, Villigen, Switzerland.
  • Reardon DA; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Wen PY; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
Neuro Oncol ; 21(1): 26-36, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30137421
No standard criteria exist for assessing response and progression in clinical trials involving patients with meningioma, and there is no consensus on the optimal endpoints for trials currently under way. As a result, there is substantial variation in the design and response criteria of meningioma trials, making comparison between trials difficult. In addition, future trials should be designed with accepted standardized endpoints. The Response Assessment in Neuro-Oncology Meningioma Working Group is an international effort to develop standardized radiologic criteria for treatment response for meningioma clinical trials. In this proposal, we present the recommendations for response criteria and endpoints for clinical trials involving patients with meningiomas.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Processos e Resultados em Cuidados de Saúde / Ensaios Clínicos como Assunto / Guias de Prática Clínica como Assunto / Neuroimagem / Neoplasias Meníngeas / Meningioma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Processos e Resultados em Cuidados de Saúde / Ensaios Clínicos como Assunto / Guias de Prática Clínica como Assunto / Neuroimagem / Neoplasias Meníngeas / Meningioma Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos